The next board meeting for VistaGen Therapeutics Inc is on 18 Sep 2025 for the purpose of TD Cowen 5th Annual Novel Mechanisms in Neuropsychiatry ConferenceSee details
VistaGen Therapeutics Inc has a share price target of US$ 14, revenue growth forecast of 18.4%, and profit growth estimate of -27.7% for FY26, based on top 5 analyst calls.